Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityNo recent work listed

Kai Song

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2011: 2 papers

Papers 2

  1. Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling. Co-author DOI 10.1042/bj20110297↗
  2. Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer. Co-author DOI 10.4161/cbt.12.5.15957↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ping Li · 1 shared paper, 2011 · strength 0.03
  2. Kan Ding · 1 shared paper, 2011 · strength 0.03
  3. Ping Li · 1 shared paper, 2011 · strength 0.03
  4. Chenghao Shao · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.